Evidence map›Paper›PMID 17957229›Full record

ArticleEuropean journal of human genetics : EJHG2008

Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease.

Yvonne Bombard, Elizabeth Penziner, Oksana Suchowersky, Mark Guttman, Jane S Paulsen, Joan L Bottorff, Michael R Hayden

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Locus of control in patients with Huntington disease: a cross-sectional study.The Journal of the Canadian Chiropractic Association · 2020
    Article
  9. Article
  10. Article
  11. The Genetic Non-Discrimination Act: critical for promoting health and science in Canada.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2018
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Factors associated with experiences of genetic discrimination among individuals at risk for Huntington disease.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2011
    Article
  18. In their own words: reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND-HD study.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2010
    Article
  19. Article
  20. Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yvonne BombardDepartment of Medical Genetics, Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
Elizabeth Penziner
Oksana Suchowersky
Mark Guttman
Jane S Paulsen
Joan L Bottorff
Michael R Hayden

Funding

NEUROBIOLOGICAL PREDICTORS OF HUNTINGTON'S DISEASER01NS040068 · NINDS · UNIVERSITY OF IOWA · PI PAULSEN, JANE S · 2001 to 2013
$48.5M
NINDS NIH HHS 3 R01 NS040068NINDS NIH HHS R01 NS040068
6 · The paper itself

Abstract

It has been over 20 years since the inception of predictive testing for Huntington disease (HD), yet the social implications of knowing one's genetic risk for HD have not been fully explored. Genetic discrimination (GD) is a potential risk associated with predictive testing. Although anecdotal reports of GD have been documented, there is a paucity of research on the nature and experiences of GD in the context of HD. The purpose of this study was to describe the concerns and experiences of GD in the HD community. Semistructured interviews were conducted with 45 genetically tested and 10 untested individuals and analyzed using grounded theory methods. Our findings demonstrate that a majority of individuals were concerned about (37/55) and experienced GD (32/55) across a variety of contexts that extend beyond the traditionally examined contexts of insurance and employment to include family, social, government, and health-care domains. We describe a process of engagement with GD in which individuals formed meaningful interpretations of GD and personalized its risk and consequences in their lives. Our findings provide an insight into some of the specific processes and factors influencing engagement with GD. These results help identify areas where more education and support is needed and provide direction to genetic professionals supporting their clients as they confront issues of GD and genetic testing.

Indexed as

PrejudiceFemaleGenetic Predisposition to DiseaseGenetic TestingHumansHuntington DiseaseMale

Identifiers

PMID17957229
PMCPMC3806301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.